Skip to main content
. 2020 Aug 6;46(4):1571–1581. doi: 10.3892/ijmm.2020.4694

Figure 1.

Figure 1

Selection and verification of miR-483-3p. (A) Expression of miR-483-3p in femur tissues of patients with osteoporosis and normal bone tissues according to GSE74209. (B) expression of miR-483-3p in the osteoblast precursors, bone marrow-derived mesenchymal stem cells (BMSCs), on days 0 and 7 of osteogenic differentiation induction according to GSE115197. (C) Expression of miR-483-3p in osteogenically differentiated or undifferentiated BMSCs according to GSE19232. (D and E) Representative images of H&E staining and Masson's staining of normal bone tissues and osteoporotic bone tissues. (F) Expression of miR-483-3p in 6 normal bone tissues and 6 osteoporotic bone tissues determined by RT-qPCR. *P<0.05, **P<0.01.